(Q39096986)

9 September 2017

title

Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines (English)

1 reference

9 September 2017

1 reference

1 reference

Sandra M Axiak-Bechtel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jeffrey N Bryan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Thomas J. Rosol

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Senthil R Kumar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kristin K Dank

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Nicole A Clarkson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kim A Selting

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jahna Espinosa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Charles J Decedue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

13 September 2013

1 reference

Investigational New Drugs

9 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1609-1615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026433%20AND%20SRC:MED&resulttype=core&format=json

Promotion of microtubule assembly in vitro by taxol

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Paclitaxel and its formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Formulating paclitaxel in nanoparticles alters its disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Nanotechnology for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Effective chemotherapy for hormone-refractory prostate cancer (HRPC): present status and perspectives with taxane-based treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Prostate cancer in dogs: comparative and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Translation of new cancer treatments from pet dogs to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

A population study of neutering status as a risk factor for canine prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Guiding the optimal translation of new cancer treatments from canine to human cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Spontaneously occurring tumors of companion animals as models for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

PC3 is a cell line characteristic of prostatic small cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

A novel canine model for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0006-0

Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs

21 January 2018

1 reference

12 December 2020

Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer

1 reference

12 December 2020

Low PSA metastatic androgen- independent prostate cancer

1 reference

12 December 2020

Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax

1 reference

12 December 2020